[1]
Sardar Al-Noori, A. et al. 2019. The significance of serum anti- rituximab (anti-CD20 monoclonal antibody) antibodies in treatment response of patients with B- cells malignancy. Al-Kufa University Journal for Biology. 11, 2 (May 2019), 8–14. DOI:https://doi.org/10.36320/ajb/v11.i2.8159.